CMS Open Payments · Program Year 2024
Seigla Medical, Inc.
Seigla Medical, Inc. reported $651,099.71 across General Payments, Research, and Ownership to 12 physicians and teaching hospitals across 15 transactions.
- $651.1K
- All-tracks total
- 15
- Transactions
- 12
- Recipients
- #708
- of 1,925 companies
Seigla Medical, Inc. reported $651,099.71 across all CMS Open Payments tracks (General + Research + Ownership) to 12 physicians and teaching hospitals in Program Year 2024 - ranking #708 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,101.71, averaging $54.3K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer seigla-medical-inc Seigla Medical, Inc.
$651.1K · #708/1,925 · 0.0% industry · PY2024
- TOT $651.1K
- RANK #708
- SHARE 0.0%
- TXN 15
- RCP 12
- CAT 1
- GEN $1.1K
- TOP1 19.6%
- PY 2024
Volume peers
Nearest volume peer: Novo Nordisk Health Care AG ($647.6K)
Seigla Medical, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Seigla Medical, Inc.
Seigla Medical, Inc. ranks #708 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $651,099.71 across 15 transactions to 12 physicians and teaching hospitals - $43.4K per transaction and $54.3K per recipient on average.
Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $1.1K across 12 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Seigla Medical, Inc. made 1 types of general payments. "Food and Beverage" is the largest category at $1.1K, 100.0% of General Payments.
How Seigla Medical, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $1.1K | 12 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $582.84 (52.9%) of $1,101.71 in this company's General Payments records across 11 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Seigla Medical, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Ray Michael Wyman
$216.22 across 2 reported transactions
- 2
Jeremy Rier
$92.75 across 1 reported transactions
- 3
William Nicholson
$91.29 across 1 reported transactions
- 4
Alex Truesdell
$91.29 across 1 reported transactions
- 5
Jared Romeo
$91.29 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Seigla Medical, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Seigla Medical, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Seigla Medical, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Fusion Orthopedics USA, LLC
Wilson Cook Medical Incorporated
Enterra Medical, Inc.
BioCryst US Sales Co., LLC
Carlsmed, Inc.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.